These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32886822)

  • 1. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
    Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
    J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proton pump inhibitors and the risk of cholangitis: a nationwide cohort study.
    Min YW; Kang D; Shin JY; Kang M; Park JK; Lee KH; Lee JK; Lee KT; Rhee PL; Kim JJ; Guallar E; Cho J; Lee H
    Aliment Pharmacol Ther; 2019 Oct; 50(7):760-768. PubMed ID: 31448440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study.
    Hwang IC; Chang J; Park SM
    PLoS One; 2018; 13(9):e0203918. PubMed ID: 30208110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitor Use Increases Pyogenic Liver Abscess Risk: A Nationwide Cohort Study.
    Oh JH; Kang D; Kang W; Guallar E; Cho J; Min YW
    J Neurogastroenterol Motil; 2021 Oct; 27(4):555-564. PubMed ID: 34642276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
    Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
    Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
    Weitsman S; Celly S; Leite G; Mathur R; Sedighi R; Barlow GM; Morales W; Sanchez M; Parodi G; Villanueva-Millan MJ; Rezaie A; Pimentel M
    Dig Dis Sci; 2022 Jan; 67(1):224-232. PubMed ID: 33534012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
    Hwang IC; Chang J; Park SM
    PLoS One; 2017; 12(12):e0189114. PubMed ID: 29216279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C.
    Kao WY; Su CW; Chia-Hui Tan E; Lee PC; Chen PH; Tang JH; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
    Hepatology; 2019 Mar; 69(3):1151-1164. PubMed ID: 30175498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors.
    Baek YH; Kang EJ; Hong S; Park S; Kim JH; Shin JY
    Int J Cancer; 2022 Apr; 150(8):1291-1300. PubMed ID: 34877670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor use and the risk for Parkinson's disease: A nationwide population-based study in Taiwan.
    Chen HL; Lei WY; Wang JH; Bair MJ; Chen CL
    Medicine (Baltimore); 2023 May; 102(19):e33711. PubMed ID: 37171333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study.
    Lin SH; Chang YS; Lin TM; Hu LF; Hou TY; Hsu HC; Shen YC; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
    Front Immunol; 2021; 12():736036. PubMed ID: 34659225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease.
    Choden T; Zhang H; Sakuraba A
    Ann Med; 2023 Dec; 55(1):2198775. PubMed ID: 37070427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan.
    Chen HY; Lin JJ; Yang B; Lin MC
    Clin Rheumatol; 2020 Sep; 39(9):2773-2780. PubMed ID: 32152918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
    Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
    Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
    Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
    PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.